Correlation Between NeuPath Health and OrganiGram Holdings

Can any of the company-specific risk be diversified away by investing in both NeuPath Health and OrganiGram Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NeuPath Health and OrganiGram Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NeuPath Health and OrganiGram Holdings, you can compare the effects of market volatilities on NeuPath Health and OrganiGram Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NeuPath Health with a short position of OrganiGram Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of NeuPath Health and OrganiGram Holdings.

Diversification Opportunities for NeuPath Health and OrganiGram Holdings

-0.04

Correlation Coefficient

NeuPath Health  OrganiGram Holdings

Good diversification

The 3 months correlation between NeuPath and OrganiGram is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding NeuPath Health and OrganiGram Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OrganiGram Holdings and NeuPath Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NeuPath Health are associated (or correlated) with OrganiGram Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OrganiGram Holdings has no effect on the direction of NeuPath Health i.e., NeuPath Health and OrganiGram Holdings go up and down completely randomly.

Pair Corralation between NeuPath Health and OrganiGram Holdings

Assuming the 90 days trading horizon NeuPath Health is expected to generate 1.1 times more return on investment than OrganiGram Holdings. However, NeuPath Health is 1.1 times more volatile than OrganiGram Holdings. It trades about 0.13 of its potential returns per unit of risk. OrganiGram Holdings is currently generating about 0.04 per unit of risk. If you would invest  17.00  in NeuPath Health on October 8, 2024 and sell it today you would earn a total of  5.00  from holding NeuPath Health or generate 29.41% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

NeuPath Health  vs.  OrganiGram Holdings

NeuPath Health

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in NeuPath Health are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, NeuPath Health showed solid returns over the last few months and may actually be approaching a breakup point.

OrganiGram Holdings

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in OrganiGram Holdings are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, OrganiGram Holdings may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with NeuPath Health and OrganiGram Holdings

The main advantage of trading using opposite NeuPath Health and OrganiGram Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NeuPath Health position performs unexpectedly, OrganiGram Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OrganiGram Holdings will offset losses from the drop in OrganiGram Holdings' long position.

The idea behind NeuPath Health and OrganiGram Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.